Share: Facebook Twitter GooglePLus LinkedIn
Activity Provided By:

i3 Health

Optimizing Personalized Care Plans for Patients With Advanced Non-Small Cell Lung Cancer

Access Activity

Overview / Abstract:


An estimated 228,150 new cases of lung cancer are reported in the United States annually, and 142,670 people die of the disease. The major subtypes are non-­small cell (84%) and small cell (13%). Most patients with lung cancer are diagnosed at a locally advanced or metastatic stage, making systemic therapy the cornerstone of management. Although 70% of patients receiving first-line classical doublet chemotherapy demonstrate clinical benefit, most develop progressive disease within 5 months of their final cycle. Recently, the use of tumor histology in determining optimal treatment strategies and relevant molecular biomarkers to further refine selection of novel therapies has improved outcomes for some patients. However, the 5-year survival rates remain dismal for both non-small cell (18%) and small cell lung cancer (5% to 10%), indicating a need for continued research on more effective approaches to tumor control.


Oncologists, pathologists, oncology advanced practitioners, oncology nurses, and other health care professionals involved in the treatment of patients with non-small cell lung cancer (NSCLC).


Upon completion of this activity, participants should be able to:

1.) Assess predictive and prognostic markers that can inform personalized care plans for patients with advanced NSCLC
2.) Evaluate current and emerging data on first-line, second-line, and salvage therapy for patients with advanced NSCLC
3.) Apply strategies to manage adverse events and optimize treatment outcomes of patients with advanced NSCLC

Note: The learning objectives listed above apply to nurse practitioners and registered nurses in addition to physicians.


Feb 13, 2021


Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME



Credits / Hours




Presenters / Authors / Faculty

Mark A. Socinski, MD (Chairperson)
Executive Medical Director
AdventHealth Cancer Institute

Maureen F. Zakowski, MD
Anatomic Pathology
The Mount Sinai Hospital

Victoria Sherry, DNP, CRNP, AOCNP®
Oncology Nurse Practitioner
Abramson Cancer Center

Activity Specialities / Related Topics

Oncology / Cancer / Radiation Therapy, Pathology

Sponsors / Supporters / Grant Providers

This activity is supported by an independent educational grant from Bristol-Myers Squibb.

Keywords / Search Terms

i3 Health i3 Health, non-small cell lung cancer, NSCLC, lung cancer, CME, CNE, online CME, online CNE, free CME, free CNE, free CE CME Free CE CME

Access Activity

RXinsider,, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the website or within our mobile apps. RXinsider,, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the Terms of Service. Site Map.